# OnCo record nct01482949 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct01482949/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct01482949", "NCT01482949" ;
  schema:name "A Rollover Protocol for Subjects Previously Treated With AGS-003"@en ;
  schema:description "A phase 2 trial of Rocapuldencel-T run by Argos Therapeutics, terminated."@en ;
  schema:url <https://onco.cc/trials/nct01482949/> ;
  schema:dateModified "2026-11-03"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT01482949> ;
  onco:status "historic" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:phase "2" ;
  onco:cancers <https://onco.cc/cancers/rcc/> ;
  onco:drugs <https://onco.cc/drugs/rocapuldencel-t/> ;
  onco:companies <https://onco.cc/companies/argos-therapeutics/> .